Glucosamine-6-sulphatase (6S) activity towards a series of radiolabelled heparin-derived trisaccharide substrates was determined in cultured human skin fibroblast and leucocyte homogenates, and in urine supernatants of normal individuals and patients affected with 6S deficiency [Sanfilippo D syndrome; mucopolysaccharidosis (MPS) type IIID]. The Nsulphated and N-acetylated derivatives of the trisaccharide substrate O-(a-glucosamine 6-sulphate)-
INTRODUCTION
glucosamine-6-sulphatase (6S), which has been shown to be deficient in cultured skin fibroblast and leucocyte homogenates
The sulphated glycosaminoglycans heparin and heparan sulin Sanfilippo D (MPS IID) patients [4] . We recently reported the phate are degraded from their non-reducing terminals by the purification and characterization of the major forms of 6S sequential action of at least five lysosomal sulphatases and four present in human liver that were active towards a heparinother exo-enzyme activities [1, 2] . A deficiency in humans of any derived disaccharide substrate GlcNAc6S-IdOA [5] . By the use one of the four enzyme activities that act upon the non-reducing of oligonucleotides directed against peptide sequence data terminal glucosamine residue of heparan sulphate may lead to generated from pure 6S, cDNA clones coding for 6S have been the tissue accumulation and urine excretion of partially degraded isolated [6] and the 6S gene has been localized to human heparan sulphate and may result in progressive mental rechromosome 12q14 [7] . tardation and mild skeletal deformities, which presents as the In studies concerning the development of a variety of oligo-
Sanfilippo syndrome [mucopolysaccharidosis type III (MPS III)]
saccharide structures for use as diagnostic substrates for lyso- [3] . The de-O-sulphation of a-linked glucosamine 6-sulphate somal enzymes concerned with glycosaminoglycan degradation, residues in heparan sulphate requires a specific sulphatase, we have reported a considerable effect of aglycone structure [6-2H] idonic acid or gulonic acid; Ga1NAc4S-G1cA-GalitolNAc4S, O-(/J-N-acetyl-upon expressed enzyme activity in incubations containing homogenates of cultured human skin fibroblasts, amniotic cells or leucocytes and purified human liver enzymes, for example sulphamate sulphohydrolase, 6S, iduronate-2-sulphatase and a-L-iduronidase [2, [8] [9] [10] [11] . Substrates that possess structural features of the natural substrate generally result in the greatest rate of hydrolysis and have been shown to be useful for the detection of residual enzyme activity in MPS patients. The biochemical characterization of MPS I (a-L-iduronidase-deficient) fibroblast activity towards IdoA-anM6S has allowed a correlation of residual a-L-iduronidase activity with the degree of clinical severity [12] . A study of the influence of aglycone structure upon the catalytic properties of purified human liver 6S towards heparin-derived substrates indicated that the disaccharide GlcNAc6S-IdOA and the trisaccharide substrates GlcNAc6S-IdoA2S-anM6S and GlcNS6S-IdoA2S-anM6S were acted upon by 6S 30-fold, 400-fold and 3900-fold more efficiently than the monosaccharide substrate GlcNAc6S [9] , which had been used for the routine diagnosis of MPS IIID patients [13] . GlcNAc6S-IdOA subsequently was evaluated for use as a convenient and specific substrate for the routine diagnosis of MPS IIID patients with the use of cultured skin fibroblast and leucocyte homogenates for enzyme activity; however, skin fibroblast homogenates from three MPS IIID patients had no significant 6S activity towards GlcNAc6S-IdOA [14] .
We now report the preparation and the evaluation of a series of heparin-derived trisaccharide substrates for the determination of 6S activity in leucocyte and cultured human skin fibroblast homogenates and urine supernatants. One of these substrates, GlcNAc6S-IdoA2S-anM6S, was used as a specialist substrate for the detection and characterization of residual 6S activity in cultured skin fibroblasts from MPS IIID patients.
MATERIALS AND METHODS

Materials
Heparin (prepared from bovine lung), BSA (globulin-free), glucosamine N-sulphate and N-acetylmannosamine were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Pharmacia Fine Chemicals (Uppsala, Sweden) supplied concanavalin A-Sepharose 4B, Sephadex G- 10 and Sephadex G-25 (superfine grade). Dowex AG-I X4 (100-200 mesh; Cl-form) was supplied by Bio-Rad Laboratories (Richmond, CA, U.S.A.). NaB3H4 (10 Ci/mmol) and N-acetyl [4,5,6,7,8,9- [13, 14] . Homogenates of cultured human skin fibroblasts and chorionic villus cells, homogenates of peripheralblood leucocytes and urine supernatants were prepared as described previously [15, 16] 6S and sulphamate sulphohydrolase were purified from human liver as described previously [5, 8] . Purified human liver a-Liduronidase [11] and iduronidate-2-sulphatase [10] were generously given by Dr (Fig. 1) were desalted on a Sephadex G-10 column (1 cm x 100 cm) developed in 100% (v/v) ethanol and radiolabelled by reduction with NaB3H4 (3 Ci/mmol) by the method described previously [21] . The radiolabelled tetrasaccharide fraction (26.7 ,umol) was applied to a 10 ml Dowex 1 (Cl-form) column equilibrated in 50 mM-sodium acetate buffer, pH 5.5 (buffer A). The column was washed with 50 ml of the same buffer and eluted by a linear gradient generated from buffer A and buffer A containing 3 M-LiCl by using an LKB 11300 Ultragrad gradient mixer on a 24 h program at a flow rate of 37 ml/h. Fractions (6 ml) were collected and assayed for radioactivity (Fig. 2) . The most highly sulphated tetrasaccharide eluted by 1.6 M-LiCl was concentrated and desalted on a Sephadex G-10 column (1 cm x 100 cm) developed in 100 mMammonium acetate buffer, pH 6.7, to yield 5.3 ,tmol of the tetrasaccharide IdoA2S-GlcNS6S-IdoA2S-anM6S, which was freeze-dried and stored in 100 (v/v) ethanol at -20 'C.
Preparative enzymic digestion of the substrates occurred in 2 ml of 60 /tM-sodium acetate buffer, pH 3.9, containing 50 mMNaCl and 100 ,ug of BSA/ml (buffer B) with the appropriate purified enzyme at 37 'C for 24 h. IdoA-GIcNS6S-IdoA2S-anM6S was isolated in 420% yield following the digestion of IdoA2S-GlcNS6S-IdoA2S-anM6S (1 ,Imol) with iduronate-2-sulphatase (70 munits). GlcNS6S-IdoA2S-anM6S was isolated in 86 % yield following the digestion of IdoA-GlcNS6S-IdoA2S-anM6S (0.4 ,umol) with a-L-iduronidase (30 munits). GlcNH6S-IdoA2S-anM6S was recovered in 680 yield following the digestion of GIcNS6S-IdoA2S-anM6S (0.2,umol) with sulphamate sulphohydrolase (15 munits). GIcNH6S-IdoA2S-anM6S was prepared directly in 420 yield by the incubation of IdoA2S-GlcNS6S-IdoA2S-anM6S (1.5 umol) concurrently with iduronate-2-sulphatase (70 munits), a-L-iduronidase (70 munits) and sulphamate sulphohydrolase (70munits). Dowex 1 chromatography as described above was used to separate the substrate from the products: IdoA-GlcNS6S-IdoA2S-anM6S was eluted by 1.4 M-LiCI, GlcNS6S-IdoA2S-anM6S by 1 GIcNH-IdoA2S-anM6S was prepared from the complete digestion of GlcNH6S-IdoA2S-anM6S (50 nmol) by glucosamine-6-sulphatase (5 munits) in 0.5 ml of buffer B at 37 'C for 24 h. The mixture was desalted and the product purified by preparative high-voltage electrophoresis. GlcNH-IdoA2S-anM6S and GlcNH6S-IdoA2S-anM6S were each quantitatively N-acetylated [22] to yield GlcNAc-IdoA2S-anM6S and GicNAc6S-IdoA2S-anM6S respectively, or N-sulphated [22] to yield GlcNS-IdoA2S-anM6S and GlcNAc6S-IdoA2S-anM6S respectively. The trisaccharide substrates were further purified by preparative highvoltage electrophoresis.
Analytical digestion of substrates involved the incubation of 1 1ul of purified enzyme (0.1 munit) or 5 ,tg of skin-fibroblast homogenate protein in an assay mixture containing 4 /tM substrate, 60 mM-sodium acetate buffer, pH 3.9, and 100 ,ug of BSA/ml in a total volume of 10 ,u at 37 'C for 2-24 h. Separation of products from the substrates was by high-voltage electrophoresis. Analytical HNO2 degradation of the radiolabelled substrates at pH 1.5 and at pH 4.0 following de-N-acetylation with hydrazine [231 was as described previously [20, 24] . Products were analysed by descending paper chromatography or by highvoltage electrophoresis and compared with a standard, IdoA2S-anM6S [19] .
6S enzyme assay
The standard enzyme assay mixture contained 4/tMGlcNAc6S-IdoA2S-anM6S in 60 mM-sodium acetate buffer, pH 3.9 (fibroblast homogenate), pH 4 4 /tM-GIcNS6S-IdoA2S-anM6S and 4 /tM-GlcNH6S-IdoA2S-anM6S were determined in 60 mmsodium acetate buffer, pH 3.9, in a total volume of 10 lO at 37 'C for 10 min (GlcNS6S-IdoA2S-anM6S) or 4 h (GIcNH6S-IdoA2S-anM6S), and the products were separated from the reactants by high-voltage electrophoresis.
Chromatofocusing of 6S activity A 1 litre volume of morning void urine from a normal healthy adult male was concentrated to 50 ml in an Amicon ultrafiltration stirred cell containing a YM 10 membrane and dialysed for 16 h at 4 'C against 2 litres of 15 mM-sodium dimethylglutarate buffer, pH 6.0, containing 500 mM-NaCl and 0.1 mM-dithioerythritol (buffer C). After centrifugation at 4000 g for 10 min, the supernatant was applied to a 25 ml column of concanavalin ASepharose equilibrated in buffer C. The column was washed Vol. 282 with 200 ml of buffer C and eluted with 200 ml of buffer C containing 150% (w/v) methyl cx-mannoside. The The column was washed with 45 ml of buffer D before the application of 160 ml of 1:8 dilution of Polybuffer 74/HCI, pH 4.0, followed by 50 ml of the same buffer containing 500 mMNaCl. Urine 6S activity was detected by activity towards GlcNAc6S-IdOA [5] . Human liver (50 g) was homogenized in 3 vol. of buffer C, centrifuged at 25000 g for 30 min as previously described [25] and processed as described above. Cultured normal human skin fibroblasts from four 50 ml culture bottles were harvested at confluence as previously described [15, 16] , freezethawed six times in 500 ,ul of buffer C and dialysed for 16 h at 4°C against 200 ml of buffer D. The suspension was centrifuged at 4000 g for 10 min and the supernatant was applied to a 3 ml PBE 94 column equilibrated in buffer D. The column was washed with 15 ml of buffer D before the application of 30 ml of a 1:8 dilution of Polybuffer 74/HCI, pH 4.0, followed by 6 ml of the same buffer containing 500 mM-NaCl. Skin fibroblast 6S activity was detected by activity towards GIcNAc6S-IdoA2S-anM6S and GlcNAc6S-IdOA.
RESULTS
Preparation of substrates
Limited HNO2 degradation of bovine lung heparin at pH 1.5 resulted in the production of a disaccharide fraction and highermolecular-mass oligosaccharides, which were separated by Sephadex G-25 chromatography (Fig. 1 ). The tetrasaccharide fraction was separated by Dowex 1 ion-exchange chromatography into fractions according to their degree of 0-and Nsulphation (Fig. 2) . The most highly sulphated fraction, proposed to be the pentasulphated tetrasaccharide IdoA2S-GlcNS6S-IdoA2S-anM6S, migrated further towards the anode upon highvoltage electrophoresis analysis compared with a previously described tetrasulphated tetrasaccharide Gal6S-GlcNAc6S-Gal6S-anM6S [28] . Each of the other Dowex 1 fractions contained a number of tetrasaccharides differing in their position of 0-sulphation and internal glucosamine N-sulphation or Nacetylation and were not characterized further. Deamination of IdoA2S-GlcNS6S-IdoA2S-anM6S by HNO2 at pH 1.5 gave only IdoA2S-anM6S, as determined by high-voltage electrophoresis and by paper chromatography. The pentasulphated tetrasaccharide was resistant to treatment with hydrazine used to de-N-acetylate N-acetylglucosamine residues and to HNO2 degradation at pH 4.0 under conditions specific for non-substituted glucosamine residues, which indicated that the internal glucosamine residue was N-sulphated. The pentasulphated tetrasaccharide was also resistant to heating at 80°C for 30 min in 20 mM-H2SO4 reported to hydrolyse internal 2-deoxy-2-Cformyl-D-pentofuranosyl residues that result from an alternate ring contraction and deamination [20] .
The availability of highly purified heparan sulphate degradation enzymes and MPS skin-fibroblast cell lines enabled the controlled stepwise degradation of the IdoA2S-GlcNS6S-IdoA2S-anM6S to proceed as described in Scheme 1, which also provided strong evidence of the substrate structures. On an analytical scale, the conversion of substrate into product following incubation with purified enzymes was more than 95 % complete and was monitored by high-voltage electrophoresis at pH 1.7 (Fig. 3) . IdoA2S-GlcNS6S-IdoA2S-anM6S was degraded ldoA2S-GIcNS6S-ldoA2S-anM6S
Id2S MPS 11
ldoA-GlcNS6S-ldoA2S-anM6S ( ). Arrows indicate the positions of VJ (void volume) and the following oligosaccharides: a, heparin-derived octasaccharide; b, GaINAc4S-GlcA-GalNAc4S-GlcA-GalitolNAc4S [26] ; c, GlcNS-UA-GlcNS-UOA [27] ; d, GalNAc4S-GlcA-GalitolNAc4S [26] ; e, IdoA2S-anM6S [19] ; f, IdoA-anM6S [19] ; g, N-acetyl [4, 5, 6, 7, 8, 9 -14C]neuraminic acid. IdoA2S-anM6S. a-N-Acetylglucosaminidase activity present in MPS II skin fibroblasts degraded GlcNAc-IdoA2S-anM6S to yield IdoA2S-anM6S. Degradation did not occur in the presence of 5 mM-N-acetylmannosamine (an inhibitor ofa-N-acetylglucosaminidase [30] ) or following the incubation of GlcNAc-IdoA2S-anM6S with MPS IIIB (a-N-acetylglucosaminidase-deficient) fibroblasts. Prolonged incubations, with a normal control fibroblast homogenate, completely degraded GlcNAc6S-IdoA2S-anM6S and GlcNAc-IdoA2S-anM6S to the monosaccharide anM6S. The degradation of IdoA2S-GlcNS6S-IdoA2S-anM6S to yield anM6S following overnight incubation with a control skin-fibroblast homogenate in the presence of acetyl-CoA was not observed because of inhibition of each of the sulphatases by acetyl-CoA. The stepwise degradation of IdoA-GlcNS6S-IdoA2S-anM6S to yield GlcNH6S-IdoA2S-anM6S on a preparative scale resulted in from 42 to 860% conversion of each substrate to product.
IdoA2S-GlcNS6S-IdoA2S-anM6S was degraded more efficiently to GlcNH6S-IdoA2S-anM6S in 42 % overall yield by the simultaneous hydrolysis by purified iduronate-2-sulphatase, a-L-iduronidase and sulphamate sulphohydrolase activities. GlcNH6S-IdoA2S-anM6S was chemically N-sulphated and Nacetylated to yield GlcNS6S-IdoA2S-anM6S and GlcNAc6S-IdoA2S-anM6S respectively. GlcNAc6S-IdoA2S-anM6S and GlcNAc-IdoA2S-anM6S were degraded by HNO2 at pH 4.0, but only following de-N-acetylation with hydrazine. GlcNH6S-
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IdoA2S-anM6S and GlcNH-IdoA2S-anM6S were degraded by HNO2 at pH 4.0, and IdoA-GlcNS6S-IdoA2S-anM6S, GlcNS6S-IdoA2S-anM6S and GlcNS-IdoA2S-anM6S were degraded by HNO2 at pH 1.5. In each case HNO2 degradation gave IdoA2S-anM6S as the only radiolabelled product detected by high-voltage electrophoresis and paper chromatography.
Determination of fibroblast 6S activity
High-voltage electrophoresis of the whole incubation mixture was used to assess the level of desulphation by the enzyme preparations (Fig. 3) . The addition of 0.1 M-NaCl to the electrophoresis buffer (0.7 M-formic acid, pH 1.7) substantially improved the resolution of the product(s) from the substrate. Skin fibroblast activity towards GlcNS6S-IdoA2S-anM6S produced three products, GlcNS-IdoA2S-anM6S and GlcNH6S-IdoA2S-anM6S, resulting from both 6S and sulphamate sulphohydrolase activity towards the original substrate, and GlcNH-IdoA2S-anM6S, which resulted from subsequent sulphatase activity towards both of these products (Fig. 3c and Scheme 1). Skinfibroblast homogenate sulphamate sulphohydrolase acted towards GlcNS6S-IdoA2S-anM6S with from 1.1-fold to 8.1-fold the rate of 6S-activity as determined by the amounts of the respective products formed (Table 1 ). Attempts to inhibit the competing sulphamate sulphohydrolase activity with CuCI2 [8] and Na2SO3 [31] were unsuccessful. Fig. 3(d) shows the electrophoretic separation of a reaction mixture following the incubation of a normal fibroblast homogenate with GlcNAc6S-IdoA2S-anM6S, which gave up to three products following 6S activity, namely GlcNAc-IdoA2S-anM6S as well as IdoA2S-anM6S and IdoA-anM6S, which result from subsequent a-N-acetylglucosaminidase and iduronate-2-sulphatase activity. N-Acetylmannosamine (5 mM) completely inhibited fibroblast a-Nacetylglucosaminidase activity towards GlcNAc-IdoA2S-anM6S at pH 3.9, but did not affect 6S activity towards GlcNAc6S-IdoA2S-anM6S, and was included in subsequent incubations to result in the formation of a single product (Fig. 3d) . Whereas purified human liver 6S acted towards G1cNAc6S-IdoA2S-anM6S 10-fold more efficiently than towards GicNAc6S-IdoA2S-anM6S [9] , 6S activity present in fibroblasts from a normal control and a sulphamate sulphohydrolase-deficient (MPS IIIA) patient acted towards both substrates with similar activity (Table  1) . GlcNH6S-IdoA2S-anM6S was hydrolysed from 13-fold to 18-fold more slowly than either of the other two trisaccharide substrates. G1cNAc6S-IdoA2S-anM6S was therefore evaluated as a substrate for the detection and characterization of 6S activity in normal and MPS IIID fibroblast homogenates.
6S activity towards GlcNAc6S-IdoA2S-anM6S
Maximal sulphatase activity towards GlcNAc6S-IdoA2S-anM6S by homogenates of cultured control skin fibroblasts was observed in 60 mM-sodium acetate buffer at pH 3.9 (Fig. 4a) . 6S activity assayed in 60 mM-sodium formate or 15 mM-sodium dimethylglutarate buffer, pH 3.9, was decreased by 52 0% and 73 % respectively. Skin-fibroblast 6S activity from MPS IIIB and MPS IIIC patients both exhibited a similar pH optima (results not shown). Control leucocyte sulphatase activity was maximal at pH 4.1 (Fig. 4a) . 6S activity was linear for incubations at 37°C containing 0.3-3,ug of homogenate protein for up to 19 h, and for up to 300% conversion of substrate into product for both control fibroblast and leucocyte homogenates. BSA at a concentration of 100 ,tg/ml did not significantly affect control skinfibroblast 6S activity; however, activity towards GlcNAc6S-IdoA2S-anM6S was inhibited 47 % by the addition of 1 mg of BSA/ml. Control fibroblast 6S activity towards GlcNAc6S-IdoA2S-anM6S was not influenced by the addition of 5 mMCuCl2, but was inhibited 500 by 75 mM-NaCl, 40 ,aM-Na2SO4 and 100 uM-NaH2PO4.
6S activity in homogenates of cultured human skin fibroblasts and leucocytes from normal control, MPS IIID and other MPS patients is shown in Fig. 5 controls and MPS patients ranged from 66.5 to 127.0 and from 37 to 81 pmol/min per mg of protein respectively. Previously fibroblast 6S activity towards GlcNAc6S-IdOA and ,-hexosaminidase activity in all MPS-patient cell lines other than MPS IIID were shown to be elevated above the normal range, whereas MPS-patient leucocyte sulphatase activity was lower than normal [14] . Sulphatase activity towards GlcNAc6S-IdoA2S-anM6S in both leucocyte and fibroblast homogenates from MPS IIID obligate heterozygotes lay between the normal and MPS IIID values (Fig. 5) . 6S fibroblast activity from an ML III (I-cell) patient lay below the normal range. 6S activity was detected in chorionic villus tissue from a 12-week pregnancy with a substrate turnover of 85 pmol/min per mg of protein, which indicates the trisaccharide substrate may be useful for prenatal diagnosis for 6S deficiency.
Control fibroblast sulphatase activity towards GlcNAc6S-IdoA2S-anM6S had apparent Km values of 0. (Tables 2 and 3 ). Skin fibroblast and leucocyte activities towards GlcNAc6S-IdoA2S-anM6S each had Km values 5.5-fold lower and Vmax values up to 6.7-fold higher than for their respective activities towards the disaccharide substrate GlcNAc6S-IdOA (Table 2) .
6S activity towards GlcNAc6S-IdoA2S-anM6S in one urine supernatant was maximal at pH 4.6 ( Fig. 4b) and had a Km value 1.2-fold lower and a Vm.. value 13.3-fold higher than for activity towards GlcNAc6S-IdOA (Table 2) . 6S activity towards GlcNAc6S-IdoA2S-anM6S in a second urine supernatant had maximal activity at pH 5. 1, whereas in the presence of 100 ,ug of BSA/ml activity was increased by 2-fold at pH 5.1 and by 30-fold at pH 3.9 to result in an apparent shift in the pH optimum from 5.1 to 4.2 (Fig. 4b) . Sulphatase activity at both pH 4.2 and pH 5.1 was linear for incubation times up to 12 h, both in the presence and in the absence of BSA. Fibroblast homogenate 6S activity towards GlcNAc6S-IdoA2S-anM6S at pH 3.9 was not inhibited by the addition of urine supernatant, and therefore it is unlikely that BSA was removing the influence of an endogenous inhibitor of urine 6S activity. In the absence of BSA urine 6S activities towards GlcNAc6S-IdoA2S-anM6S at pH 4 (Table 2) . When the urine sample was concentrated 5-fold the pH optimum for activity towards GlcNAc6S-IdoA2S-anM6S, determined in the absence of BSA, shifted from pH 5.1 to 4.5, similarly to the pH optimum for the first urine sample.
Chromatofocusing of human liver, urine and fibroblast 6S activity Since the observed fibroblast and urine 6S activity towards GlcNAc6S-IdoA2S-anM6S would be the summation of individual forms of activities present in a particular enzyme preparation, we compared the different forms of 6S activity that were present in human liver, skin-fibroblast homogenates and urine supernatants. The chromatofocusing profile for human liver 6S activity was similar to that observed for 6S activity following elution from the combined concanavalin A-Sepharose/Blue Aagarose step [5] , and the Blue-A-agarose column did not remove any forms of 6S activity. [20, 23, 32] and to product simple disaccharide substrates for enzymes that normally act towards more complex oligosaccharides, namely iduronate-2-sulphatase [19] , a-L-iduronidase [12, 19] , glucuronate-2-sulphatase [33, 34] and fl-D-glucuronidase [19, 35] . In this study we have shown that limited HNO2 degradation of bovine lung heparin produced a pentasulphated tetrasaccharide, IdoA2S-GIcNS6S-IdoA2S-anM6S, which resulted from the incomplete degradation of the internal glucosamine N-sulphate residues. The degradation of IdoA2S-GlcNS6S-IdoA2S-anM6S with purified enzymes on a preparative scale resulted in poorer yields compared with the quantitative yields obtained on analytical scale. We have pre- viously observed that many of the heparan sulphate-degrading enzymes are susceptible to both substrate and product (including sulphate) inhibition [2, [8] [9] [10] . IdoA2S-GlcNS6S-IdoA2S-anM6S is identical with the tetrasaccharide 11-4NS prepared by Weissmann & Chao [36] by an alternative procedure. Degradation of tetrasaccharide 11-4NS by partially purified bovine liver hydrolases gave the trisaccharide GlcNH6S-IdoA2S-anM6S, which was chemically N-acetylated or N-sulphated to yield GlcNAc6S-IdoA2S-anM6S and GlcNS6S-IdoA2S-anM6S respectively [31] . Bovine kidney 6S acted towards GlcNS6S-IdoA2S-anM6S with a Km value of 0.5 mm [37] , whereas human liver 6S acted towards the substrate with a Km value of 0.25 /LM at pH 4.1 [9] .
The more efficient turnover of the complex trisaccharide substrates GIcNS6S-IdoA2S-anM6S and GlcNAc6S-IdoA2S-anM6S compared with the structurally simpler substrate
GlcNAc6S-IdOA currently used for the detection of MPS IIID patients [14] confirms the influence of aglycone substrate structure upon enzyme activity that we have reported for purified human liver 6S [9] and sulphamate sulphohydrolase [2, 8] . Whereas purified human liver 6S acted towards GlcNS6S-IdoA2S-anM6S 10-fold more efficiently than towards GlcNAc6S-IdoA2S-anM6S [9] , fibroblast 6S activity towards both substrates was observed to be similar. We have previously shown that there is considerable substrate inhibition of purified human liver 6S activity towards GlcNS6S-IdoA2S-anM6S, particularly at substrate concentrations above S ,uM, which was not observed for activity towards GlcNAc6S-IdoA2S-anM6S [9] . Other heparan sulphate-degrading enzymes present in the fibroblast homogenate may also compete for the binding of the substrates, since it has been shown many enzyme activities including 6S are inhibited by oligosaccharide analogues that are substrates for other heparindegrading enzyme activities [2, [8] [9] [10] [11] 33] . Both of the urine and fibroblast 6S activities were shown by chromatofocusing to be the summation of many individual forms of activity. Although it is likely that the forms of 6S present in various tissues may have different kinetic parameters, 6S activities towards GlcNAc6S-IdoA2S-anM6S in fibroblasts, leucocytes and urine (when assayed in the presence of BSA) were shown to have similar Km values and pH optima, and were inhibited by NaCl, Na2SO4 and NaH2PO4 at concentrations similar to that reported for human liver form A [9] . Each form of fibroblast 6S activity separated by chromatofocusing had similar relative activities towards both GlcNAc6S-IdoA2S-anM6S and GlcNAc6S-IdOA and was also present in liver and/or urine. Human liver form A, form B and form C activities towards each of several heparin-derived disaccharide substrates had similar Km values; however, the respective kcat values for forms B and C were approximately half that observed for form A [9] . Fibroblast 6S was shown to be composed of two polypeptides with molecular masses of 82 kDa and 78 kDa, which were derived by different carbohydrate processing of the same polypeptide [38] . Human liver form A had a single 78 kDa polypeptide, whereas forms B and C contained 48 kDa and 32 kDa polypeptides. Purified human urine 6S had a single polypeptide of molecular mass 99 kDa [39] . Proteolytic and/or oligosaccharide processing may account for the changes in ph values of the forms separated by chromatofocusing and represent different stages of maturation of the mature enzyme. Processing appears to influence the catalytic event rather than the binding of the substrate to the enzyme (Kin).
We have previously reported both the enhancement of activity and stability of purified human liver 6S, sulphamate sulphohydrolase, glucuronate-2-sulphatase and iduronate-2-sulphatase following the addition of BSA to the incubation mixture [2, 5, [8] [9] [10] 33] . Human urine 6S activity towards GIcNAc6S-Vol. 282
IdoA2S-anM6S in the absence of BSA was maximal at pH 5.1, which was similar to that reported for human urine 6S activity towards GlcNAc6S-IdOA [14] and GlcNAc6S-GlcA-anM [39] . In the absence of BSA urine 6S activity bound both the disaccharide and trisaccharide substrates with similar affinities, which suggests that at the higher pH the influence of the aglycone IdoA2S residues may be diminished compared with its effect at low pH. Whereas BSA enhanced the Vaax value of urine 6S activity towards GlcNAc6S-IdoA2S-anM6S at pH 5.1 without alteration of the Km value, as was observed for purified liver 6S activity towards GlcNAc6S-IdOA at pH 5.0 [9] , BSA stimulated urine 6S activity at pH 4.2 by both decreasing the apparent Km value and increasing the Vmax value (Table 2 ). It is possible that BSA may be preferentially stimulating a low-Km form of urine 6S activity at pH 4.2. Purified rat preputial-gland and partially purified chick-embryo liver /-D-glucuronidases were shown to exist both in a low-Km form at pH 3.0, which was stimulated by BSA, and a high-Km form at pH 5.5 [40, 41] . BSA may therefore be replacing some unknown activator in vivo that may be diluted with the urine or be purified away from the liver enzyme.
To date, of six MPS IIID patients described in the literature, only one has a mild phenotype [42] [43] [44] . Although fibroblasts from one patient had no detectable 6S activity towards GlcNAc6S-GlcA-anM, each of the other MPS IIID fibroblasts tested from both the mild and the severely affected patients had similar residual activity of 0.33-0.38 pmol/min/mg protein [42] [43] [44] . No significant 6S activity towards GlcNAc6S-IdOA was detected in MPS-IIID-fibroblast homogenates [14] , although normal fibroblast 6S activity towards GlcNAc6S-GlcA-anM and GlcNAc6S-IdOA were reported to be similar [14, 39] . Each of the MPS IIID cell lines tested had residual 6S activity towards GlcNAc6S-IdoA2S-anM6S and had a pH optimum and Km values for activity towards GlcNAc6S-IdoA2S-anM6S similar to those of the normal controls, although the Vmax values were less than 1 hO of the normal range. Skin fibroblasts from an MPS IIID patient were shown to have normal size and quantity of mRNA encoding for 6S; however, there was a deficiency of 6S-protein-cross-reactive material, which suggests a defective translation or a post-translational instability of the enzyme, which is consistent with the substantially decreased 6S activity in the patient's fibroblasts [38] . However, from each of the studies reported, there does not appear to be any correlation between the clinical phenotype and residual enzyme activity measured in cultured skin-fibroblast homogenates for 6S activity [38, [42] [43] [44] .
In conclusion, we have shown that the series of heparinderived substrates described in this paper are useful as model oligosaccharides for studying the activities and interactions of the enzymes that degrade heparan sulphate. GlcNAc6S-IdoA2S-anM6S was particularly useful for the detection and characterization of specific 6S residual enzyme in MPS IIID patients' tissues. When used in conjunction with recombinant DNA procedures for the analysis of 6S gene defects, the determination of residual 6S activity may be invaluable for the prediction of the clinical phenotype of MPS IIID patients [45] .
